Market Research Industry Reports

Spectrum Pharmaceuticals Inc (SPPI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The companys marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection); Zevalin (ibritumomab tiuxetan); Marqibo (vincristine sulfate liposome injection), Beleodaq (belinostat) and Evomela (Captisol-Enabled Melphalan). It also has drugs in mid-to-late stage development, namely, Rolontis (eflapegrastim) for chemotherapy-induced neutropenia; Qapzola (apaziquone) for Intravesical Instillation; and Poziotinib for the treatment of various types of cancers. The company markets its products through direct sales force in the US and through distributors in Europe. Spectrum is headquartered in Henderson, Nevada, the US.

Spectrum Pharmaceuticals Inc (SPPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Spectrum Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
myTomorrows Enters into Agreement with Spectrum Pharma 14
Spectrum Pharma Enters into Agreement with Servier Canada 15
Eagle Pharma Enters into Agreement with Spectrum Pharma 16
Licensing Agreements 17
Spectrum Pharma Enters into Licensing Agreement with University of Texas MD Anderson Cancer 17
Mundipharma Enters into Licensing Agreement with Spectrum Pharma for Zevalin 18
Spectrum Pharma Enters into Licensing Agreement with Hanmi Pharma for Poziotinib 20
Spectrum Pharma Enters into Licensing Agreement with CASI for Zevalin, Marqibo and Captisol-Enabled Melphalan 21
Ligand Pharma Enters Into Licensing Agreement With Spectrum Pharma For Captisol-Enabled Melphalan 23
Spectrum Pharma Amends Licensing Agreement With Allergan For Apaziquone 25
Spectrum Pharma Enters Into Licensing Agreement With Bayer Healthcare For Zevalin 26
Spectrum Pharma Enters Into Licensing Agreement With Hanmi Pharma For SPI-2012 27
Spectrum Pharma Amends Licensing Agreement With TopoTarget For Belinostat 28
Equity Offering 29
Spectrum Pharma Plans to Raise up to USD150 Million in Private Placement of Shares 29
Spectrum Pharma Raises USD3 Million in Private Placement of Shares 30
Talon Therapeutics Completes Private Placement Of Preferred Stock For US$11 Million 31
Debt Offering 33
Spectrum Pharma Completes Private Placement Of Notes Due 2018 For US$100 Million 33
Acquisition 35
Spectrum Pharma Acquires Majority Stake In Talon Therapeutics 35
Spectrum Pharma Completes Acquisition Of Allos Therapeutics For USD206 Million 37
Spectrum Pharmaceuticals Inc - Key Competitors 39
Spectrum Pharmaceuticals Inc - Key Employees 40
Spectrum Pharmaceuticals Inc - Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Joint Venture 42
Recent Developments 43
Financial Announcements 43
May 03, 2018: Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update 43
Mar 06, 2018: Spectrum Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results and Pipeline Update 45
Nov 02, 2017: Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update 47
Aug 03, 2017: Spectrum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Pipeline Update 49
May 02, 2017: Spectrum Pharmaceuticals Reports First Quarter 2017 Financial Results and Pipeline Update 50
Mar 08, 2017: Spectrum Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results and Pipeline Update 51
Corporate Communications 53
Feb 27, 2018: Spectrum Pharmaceuticals Announces Appointment of William L. Ashton to its Board of Directors 53
Dec 17, 2017: Spectrum Pharmaceuticals Announces Leadership Changes 54
Product News 55
12/04/2017: Spectrum Pharmaceuticals To Present Abstracts On MARQIBO At The 59th Annual Meeting Of The ASH in Atlanta, Georgia, December 9-12, 2017 55
06/02/2017: Spectrum Pharmaceuticals Announces Presentation on MARQIBO at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, June 2-6, 2017 56
06/02/2017: Spectrum Pharmaceuticals Highlights Clinical Data on FOLOTYN at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, June 2-6, 2017 57
Product Approvals 58
Sep 07, 2017: CASI Provides Update on MARQIBO 58
Clinical Trials 59
Jun 19, 2017: Spectrum Pharmaceuticals Highlights Results of a Combination Study of FOLOTYN Plus Romidepsin Presented at the 14th International Conference on Malignant Lymphoma (14-ICML) Meeting 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List Of Tables

List of Tables
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spectrum Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Spectrum Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
myTomorrows Enters into Agreement with Spectrum Pharma 14
Spectrum Pharma Enters into Agreement with Servier Canada 15
Eagle Pharma Enters into Agreement with Spectrum Pharma 16
Spectrum Pharma Enters into Licensing Agreement with University of Texas MD Anderson Cancer 17
Mundipharma Enters into Licensing Agreement with Spectrum Pharma for Zevalin 18
Spectrum Pharma Enters into Licensing Agreement with Hanmi Pharma for Poziotinib 20
Spectrum Pharma Enters into Licensing Agreement with CASI for Zevalin, Marqibo and Captisol-Enabled Melphalan 21
Ligand Pharma Enters Into Licensing Agreement With Spectrum Pharma For Captisol-Enabled Melphalan 23
Spectrum Pharma Amends Licensing Agreement With Allergan For Apaziquone 25
Spectrum Pharma Enters Into Licensing Agreement With Bayer Healthcare For Zevalin 26
Spectrum Pharma Enters Into Licensing Agreement With Hanmi Pharma For SPI-2012 27
Spectrum Pharma Amends Licensing Agreement With TopoTarget For Belinostat 28
Spectrum Pharma Plans to Raise up to USD150 Million in Private Placement of Shares 29
Spectrum Pharma Raises USD3 Million in Private Placement of Shares 30
Talon Therapeutics Completes Private Placement Of Preferred Stock For US$11 Million 31
Spectrum Pharma Completes Private Placement Of Notes Due 2018 For US$100 Million 33
Spectrum Pharma Acquires Majority Stake In Talon Therapeutics 35
Spectrum Pharma Completes Acquisition Of Allos Therapeutics For USD206 Million 37
Spectrum Pharmaceuticals Inc, Key Competitors 39
Spectrum Pharmaceuticals Inc, Key Employees 40
Spectrum Pharmaceuticals Inc, Other Locations 41
Spectrum Pharmaceuticals Inc, Subsidiaries 41
Spectrum Pharmaceuticals Inc, Joint Venture 42

List Of Figures

List of Figures
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Spectrum Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11

Spectrum Pharmaceuticals Inc (SPPI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The companys marketed drugs

USD 250View Report

Global Tv White Space Spectrum Industry Market Research Report

The Tv White Space Spectrum market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a

USD 2960View Report

Alexza Pharmaceuticals Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous

USD 250View Report

Ra Pharmaceuticals Inc (RARX) - Medical Equipment - Deals and Alliances Profile

Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2018
No. of Pages :60
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube